Modulators of gal-4 signaling identified as potentially promising targets for remyelination in multiple sclerosis
Nov. 4, 2022
The failure to remyelinate neurons following an attack is one of the major characteristics of multiple sclerosis (MS) ultimately causing the progressive loss of neurological dysfunction.
